-
Important news
-
News
-
Shenzhen
-
China
-
World
-
Opinion
-
Sports
-
Kaleidoscope
-
Photos
-
Business
-
Markets
-
Business/Markets
-
World Economy
-
Speak Shenzhen
-
Leisure
-
Culture
-
Travel
-
Entertainment
-
Digital Paper
-
In-Depth
-
Weekend
-
Newsmaker
-
Lifestyle
-
Diversions
-
Movies
-
Hotels and Food
-
Special Report
-
Yes Teens!
-
News Picks
-
Tech and Science
-
Glamour
-
Campus
-
Budding Writers
-
Fun
-
Qianhai
-
Advertorial
-
CHTF Special
-
Futian Today
在线翻译:
szdaily -> Special Report -> 
Study: 80% of COVID-19 patients are VD deficient
    2020-10-29  08:53    Shenzhen Daily

RECENT research discovered a correlation between vitamin D deficiency and a higher risk of COVID-19. Now, another new study has found the same — noting that more than 80 percent of people with COVID-19 didn’t have adequate levels of the “sunshine vitamin” in their blood.

As part of the new study in the Journal of Clinical Endocrinology & Metabolism, researchers looked at 216 COVID-19 patients in a hospital in Spain. The scientists matched the patients to controls from another dataset.

Of all the patients, 82.2 percent were deficient in vitamin D.

People who had COVID-19 and lower vitamin D levels also had higher inflammatory markers such as ferritin and D-dimer. Those have been linked to poor COVID-19 outcomes.

People with vitamin D deficiency had a higher prevalence of hypertension and cardiovascular disease. They also had longer hospital stays for COVID-19, the study showed.

Comorbidities such as hypertension, diabetes and obesity are associated with low vitamin D status, said Hans Konrad Biesalski, a professor at the University of Hohenheim who has evaluated vitamin D and COVID-19.

“It looks like patients with a poor vitamin D status may have more severe COVID-19,” he told Healthline. But the new study didn’t find that relationship.

In addition to the correlation between vitamin D levels and COVID-19 risk, many people are looking at how it may protect people or help them recover from the disease.

“One approach is to identify and treat vitamin D deficiency, especially in high-risk individuals such as the elderly, patients with comorbidities, and nursing home residents, who are the main target population for the COVID-19,” said study co-author Jose L. Hernandez of the University of Cantabria in Santander, Spain.

He said people at high risk for COVID-19 — older adults, those with underlying conditions, and people in nursing homes — can be treated with vitamin D.

“Vitamin D treatment should be recommended in COVID-19 patients with low levels of vitamin D in the blood since this approach might have beneficial effects in both the musculoskeletal and the immune system,” Hernandez said in a statement.

(SD-Agencies)

深圳报业集团版权所有, 未经授权禁止复制; Copyright 2010-2020, All Rights Reserved.
Shenzhen Daily E-mail:szdaily@126.com